SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advik Lab - Quaterly Results

10 Jan 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 0.32 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2021 is Rs. -2.75 millions as compared to Net Loss of Rs. -37.34 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 improved to -1.65% as compared to -36.12% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 0.32 0.00 0.00 0.32 0.00 0.00 0.00 0.04 0.00
Other Income 0.00 0.05 0.00 2.54 0.14 1714.29 1.95 0.11 1672.73
PBIDT -1.65 -36.12 -95.43 -2.33 -38.98 -94.02 -39.37 -6.63 493.82
Interest 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT -1.65 -36.12 -95.43 -2.34 -38.98 -94.00 -39.38 -6.63 493.97
Depreciation 1.28 1.42 -9.86 3.84 4.26 -9.86 5.56 5.73 -2.97
PBT -2.93 -37.54 -92.19 -6.18 -43.24 -85.71 -44.94 -12.36 263.59
TAX -0.18 -0.20 -10.00 -0.52 -0.60 -13.33 -0.78 -0.70 11.43
Deferred Tax -0.18 -0.20 -10.00 -0.52 -0.60 -13.33 -0.78 -0.70 11.43
PAT -2.75 -37.34 -92.64 -5.66 -42.64 -86.73 -44.16 -11.66 278.73
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) -515.63 0.00 0.00 -728.13 0.00 0.00 0.00 -16575.00 0.00

MPS Pharmaa Share Price

1.73 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.10
Dr. Reddys Lab 1238.50
Cipla 1237.90
Zydus Lifesciences 942.00
Lupin 2334.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×